Noteably, some Bim is now found bound to Mcl-1 in the recurrent tumor (Fig. 5b), alluding to the potential for evolution of Mcl-1 dependent clone in the tumor if ABT-199 treatments are given for a longer duration of time. This evidence concerns the gene BCL2L11 and neoplasm.